In conclusion, we provide insight into the biological function of Gal-1 signaling in HCC and demonstrate that Gal-1 overexpression activates the FAK/PI3K/AKT pathway by upregulating expression of αvβ3 integrin, leading to enhanced HCC invasion via EMT and sorafenib resistance. This evidence concerns the gene AKT1 and hepatocellular carcinoma.